Key Details
Price
$1.12Annual Revenue
$1.08 MAnnual ROE
-30.45%Beta
3.14Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 12, 2024Recent annual earnings:
Feb 29, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Quantum-Si incorporated (NASDAQ:QSI ) Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ET Company Participants Doug Farrell - VP, IR Jeffrey Hawkins - President & CEO Jeffry Keyes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Operator Good day, and thank you for standing by. Welcome to the 2024 Third Quarter Quantum-Si Earnings Call.
QuantumSi Incorporated (QSI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.18 per share a year ago.
There are many risky penny stocks available, but Quantum-Si Incorporated stands out from the rest. Quantum-Si Incorporated is not your typical penny stock, as it produces and sells the Platinum protein sequencer.
Quantum-Si Incorporated (QSI) Q4 2023 Earnings Call Transcript
Quantum-Si is about to move from a controlled launch to a full scale commercial launch of its first product. It will be a groundbreaking device, a desktop Proteome sequencer at a fraction of the price of competing technology. If the product is successful, QSI stock is likely significantly undervalued.
Quantum-Si Incorporated (QSI) Q3 2023 Earnings Call Transcript
Quantum-Si incorporated is a pioneering company in the field of proteomics with its innovative Platinum platform. The company's revenue model is still in its early stages, making it a highly speculative investment. QSI's valuation is challenging but has explosive revenue potential in the growing proteomics market.
Quantum-SI released its Q2 2023 earnings report, which showed lower-than-expected revenue and reduced forward guidance. The company shelved its carbon product and identified problems with its AI software. Despite the market's negative reaction, the company has strong potential in the protein sequencing market and has a solid financial position.
Quantum-Si stock beat on earnings this morning, but suffered a sales miss. Worse than that, sales actually slowed down between Q1 and Q2.
FAQ
- What is the primary business of Quantum-Si incorporated?
- What is the ticker symbol for Quantum-Si incorporated?
- Does Quantum-Si incorporated pay dividends?
- What sector is Quantum-Si incorporated in?
- What industry is Quantum-Si incorporated in?
- What country is Quantum-Si incorporated based in?
- When did Quantum-Si incorporated go public?
- Is Quantum-Si incorporated in the S&P 500?
- Is Quantum-Si incorporated in the NASDAQ 100?
- Is Quantum-Si incorporated in the Dow Jones?
- When was Quantum-Si incorporated's last earnings report?
- When does Quantum-Si incorporated report earnings?
- Should I buy Quantum-Si incorporated stock now?